CIBC Bank USA’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,491
Closed -$223K 271
2018
Q3
$223K Buy
+2,491
New +$220K 0.03% 235
2018
Q2
Sell
-2,406
Closed -$214K 269
2018
Q1
$214K Buy
2,406
+100
+4% +$9.6K 0.03% 242
2017
Q4
$241K Sell
2,306
-470
-17% -$53K 0.03% 227
2017
Q3
$404K Buy
2,776
+630
+29% +$85.8K 0.05% 176
2017
Q2
$279K Buy
2,146
+42
+2% +$5.15K 0.04% 209
2017
Q1
$262K Sell
2,104
-53
-2% -$6.34K 0.04% 216
2016
Q4
$250K Sell
2,157
-50
-2% -$5.57K 0.04% 217
2016
Q3
$230K Sell
2,207
-95
-4% -$10.3K 0.03% 228
2016
Q2
$227K Buy
2,302
+300
+15% +$31K 0.04% 229
2016
Q1
$200K Sell
2,002
-5,479
-73% -$564K 0.04% 215
2015
Q4
$896K Sell
7,481
-577
-7% -$66.8K 0.16% 89
2015
Q3
$871K Sell
8,058
-1,285
-14% -$159K 0.16% 88
2015
Q2
$1.08M Sell
9,343
-190
-2% -$21.7K 0.18% 81
2015
Q1
$1.1M Sell
9,533
-1,539
-14% -$184K 0.19% 77
2014
Q4
$1.24M Sell
11,072
-360
-3% -$38K 0.22% 77
2014
Q3
$1.08M Buy
11,432
+289
+3% +$26.1K 0.22% 80
2014
Q2
$957K Buy
11,143
+3,439
+45% +$262K 0.18% 95
2014
Q1
$538K Sell
7,704
-1,640
-18% -$130K 0.11% 164
2013
Q4
$789K Sell
9,344
-190
-2% -$15K 0.18% 126
2013
Q3
$735K Sell
9,534
-17,758
-65% -$1.24M 0.18% 127
2013
Q2
$1.6M Buy
+27,292
New +$1.64M 0.09% 146

Other funds holding CELG

CIBC Bank USA's CELG Position: Q4 2018 in Review

CIBC Bank USA sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 2,491 shares — an estimated $223K sold.

CIBC Bank USA first reported a position in CELG in Q2 2013 and held it in 21 quarters. The position peaked at $1.6M in Q2 2013. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • CIBC Bank USA reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • CIBC Bank USA sold 2,491 Celgene Corp shares in Q4 2018, an estimated $223K.
  • CIBC Bank USA first reported a position in Celgene Corp in Q2 2013 and held it in 21 quarters.
  • CIBC Bank USA's Celgene Corp position peaked at $1.6M in Q2 2013.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on CIBC Bank USA's 13F filing for Q4 2018, filed 5 Feb 2019.